2021. Designing of heterocyclic compounds as promising VEGFR2 tyrosine kinase inhibitors: An Insilico analysis. International Journal of Pharmaceutical Sciences and Drug Research. 13, 6 (Nov. 2021), 685–698. DOI:https://doi.org/10.25004/IJPSDR.2021.130612.